噁唑并5,4-d嘧啶类化合物的设计、合成及其抗肿瘤活性

李明涛; 徐丹; 薛文君; 尤启冬; 孙丽萍

doi:10.11665/j.issn.1000-5048.20170406

噁唑并[5,4-d]嘧啶类化合物的设计、合成及其抗肿瘤活性

中国药科大学药学院药物化学教研室，江苏省药物分子设计与成药性优化重点实验室

基金项目: 国家自然科学基金资助项目(No.20872181,No.21172265) ^#李明涛和徐丹对本论文的贡献相同

计量
- 文章访问数: 947
- HTML全文浏览量: 0
- PDF下载量: 1629
出版历程
- 刊出日期: 2017-08-24

Design, synthesis and antitumor activities of oxazolo［5, 4-d］pyrimidine derivatives

摘要

摘要: 为了寻找具有更好抗肿瘤活性的化合物，设计合成了一系列GFDA2唑并［5，4-d］嘧啶类衍生物。以盐酸乙脒为起始原料，合成了13个化合物 8a ~ 8m ；目标化合物结构经IR、¹H NMR、EI-MS和元素分析确证；采用MTT法先后对目标化合物进行了人脐静脉内皮细胞(HUVEC)的抗肿瘤血管生成抑制活性测试和3株肿瘤细胞(A549、HepG2、U251)的体外抗肿瘤活性测试；结果表明，化合物 8c 、 8d 、 8g 、 8i和8l 对HUVEC和3株不同肿瘤细胞表现出明显的增殖抑制活性；化合物 8l 对A549、HepG2和U251的抑制活性略优于阳性对照药舒尼替尼，值得进一步研究。
- 噁唑并[5,4-d]嘧啶类衍生物 /
- 合成 /
- 抗血管生成 /
- 抗肿瘤活性
Abstract: A series of oxazole［5, 4-d］pyrimidine derivatives were designed and synthesized to discover novel compounds with antitumor activity. Compounds 8a - 8m were synthesized using acetamidine hydrochloride as the start material. The structures of synthesized compounds were confirmed by IR, ¹H NMR, EI-MS and elemental analysis. The antiangiogenesis activities of the synthesized compounds were determined by MTT in human umbilical vein endothelial cell(HUVEC). The in vitro antitumor activities of the synthesized compounds were determined by MTT assay in A549, HepG2 and U251. Compounds 8c , 8d , 8g , 8i and 8l were found to inhibit the proliferation of all the tested cell lines. Compound 8l exhibited noteworthy activities in A549, HepG2 and U251 cell lines with IC₅₀value lower than the positive reference sunitinib, suggesting that compound 8l might be the promising antitumor agent for further investigation.
- oxazole［5,4-d］pyrimidine derivatives /
- synthesis /
- anti-angiogenesis /
- antitumor activity

HTML全文

参考文献(12)

[1]	Zhao PL,You WW,Duan AN.Research advances in antitumor activities of pyrimidine derivatives[J].Acta Pharm Sin(药学学报),2012,47(5):580-587.
[2]	Burchat AF,Calderwood DJ,Friedman MM,et al.Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck-a selectivity insight[J].Bioorg Med Chem Lett,2002,12(12):1687-1690.
[3]	Kim S, Schiff BA, Younes MN, et al. Treatment with NVP AEE788-a dual inhibitor of EFGR and VEGFR tyrosine kinase-inhibits anaplastic thyroid carcinoma growth[J].Clin Cancer Res,2003,9(16):6100S-6101S.
[4]	Dai Y, Guo Y, Frey RR, et al. Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors[J].J Med Chem,2005,48(19):6066-6083.
[5]	Miyazaki Y,Matsunaga S,Tang J,et al.Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors[J].Bioorg Med Chem Lett,2005,15(9):2203-2207.
[6]	Miller DJ,Ravikumar K,Shen H,et al.Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibiton[J].J Med Chem,2002,45(1):90-98.
[7]	Yildiz-Oren I,Yalcin I,Aki-Sener E,et al.Synthesis and structure-activity relationships of new antimicrobial active multi substituted benzazolederivatives[J].Eur J Med Chem,2004,39(3):291-298.
[8]	Bauser M,Delapierre G,Hauswlad M,et al.Discovery and optimization of 2-aryl oxzaolo-pyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesis[J].Bioorg Med Chem Lett,2004,14(8):1997-2000.
[9]	Xu D,Sun LP,You QD.Facile synthesis of 2,5,7-trisubstituted oxazolo[5,4-d]pyrimidines via copper-catalyzed intramolecular C-O bond formation[J].Tetrahedron,2012,68(22):4248-4251.
[10]	Polverino A,Coxon A,Starnes C,et al.AMG 706,an oral,multikinase inhibitor that selectively targets vascular endothelial growth factor,platelet-derived growth factor,and kit receptors,potently inhibits angiogenesis and induces regression in tumor xenografts[J].Cancer Res,2006,66(17):8715-8721.
[11]	Mao ZW, Wan CP, Jiang Y, et al. Synthesis and anti-tumor activity in vitro of N-heterocycle substitutes benzofuranderivatives[J].J China Pharm Univ(中国药科大学学报),2015,46(1):58-61.
[12]	Liang XW,Xu FM,Li XG,et al.VEGF signal system:the application of antiangiogenesis[J].Curr Med Chem,2014,21(7):894-910.

施引文献

资源附件(0)

计量

文章访问数: 947
HTML全文浏览量: 0
PDF下载量: 1629
被引次数: 0

噁唑并[5,4-d]嘧啶类化合物的设计、合成及其抗肿瘤活性

计量

出版历程

Design, synthesis and antitumor activities of oxazolo［5, 4-d］pyrimidine derivatives

计量

出版历程

目录